N

NeuroX1 Inc.

7 employees

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Parkinson's
biotechnology
rare disease
generativeAI
Artificial Intelligence
neuroscience
AI
generative drug discovery
brain
Machine Learning
Neuroscience
pediatric rare disease
neurodegenerative
cancer
Biopharma
neurology
Life Science
Alzheimer's

Date founded

2021

Funding rounds raised

Total raised

$1.3M

from 2 investors over 2 rounds

N

NeuroX1 Inc. raised $500K on March 3, 2023

Investors: Drive Capital

N

NeuroX1 Inc. raised $1.3M on December 31, 2021

Investors: Vibe Capital

FAQ